HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Kenichi Harada Selected Research

PAcein

2/2015Canals of Hering loss relates to the progression of the histological stages of primary biliary cirrhosis.
10/2013Clinicopathological significance of serum fractalkine in primary biliary cirrhosis.
6/2013Evaluation of a new histologic staging and grading system for primary biliary cirrhosis in comparison with classical systems.
2/2013Application and validation of a new histologic staging and grading system for primary biliary cirrhosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Kenichi Harada Research Topics

Disease

75Neoplasms (Cancer)
04/2022 - 06/2002
39Cholangiocarcinoma
04/2021 - 02/2003
27Carcinoma (Carcinomatosis)
10/2022 - 02/2003
27Biliary Liver Cirrhosis (Primary Biliary Cirrhosis)
01/2021 - 08/2002
22Renal Cell Carcinoma (Grawitz Tumor)
05/2022 - 02/2016
18Fibrosis (Cirrhosis)
06/2022 - 08/2005
18Inflammation (Inflammations)
01/2022 - 08/2002
16Sclerosing Cholangitis
03/2021 - 03/2005
15Neoplasm Metastasis (Metastasis)
06/2022 - 04/2006
14Adenocarcinoma
03/2021 - 09/2003
13Cholangitis
12/2016 - 06/2005
12Hepatitis
02/2020 - 07/2002
11Prostatic Neoplasms (Prostate Cancer)
06/2022 - 01/2018
9Liver Cirrhosis (Hepatic Cirrhosis)
06/2022 - 10/2006
9Hepatocellular Carcinoma (Hepatoma)
10/2021 - 08/2008
9Immunoglobulin G4-Related Disease
01/2021 - 07/2012
9Necrosis
08/2020 - 07/2002
9Carcinogenesis
07/2017 - 09/2007
7Disease Progression
03/2020 - 09/2011
6Stomach Neoplasms (Stomach Cancer)
05/2019 - 03/2011
6Adenoma (Adenomas)
01/2018 - 06/2002
5Non-alcoholic Fatty Liver Disease
01/2022 - 02/2020
5Biliary Atresia
01/2012 - 10/2007
4Alcoholic Fatty Liver
12/2021 - 08/2010
4Fatty Liver
12/2021 - 08/2010
4Squamous Cell Carcinoma (Epidermoid Carcinoma)
08/2020 - 01/2002
4Cholestasis
02/2020 - 08/2008
4Lymphatic Metastasis
01/2020 - 09/2003
4Cysts
10/2018 - 02/2004
4Colorectal Neoplasms (Colorectal Cancer)
01/2018 - 06/2002
4Carcinoma in Situ
01/2014 - 09/2009
3Congenital Hepatic Fibrosis
08/2021 - 08/2005
3Caroli Disease (Caroli's Disease)
08/2021 - 02/2009
3Klatskin Tumor
01/2021 - 05/2013
3Hemorrhage
08/2020 - 01/2014
3Hyperplasia
04/2019 - 02/2009
3Pancreatitis
04/2019 - 06/2005
3Autoimmune Pancreatitis
02/2018 - 01/2014
3Jaundice (Icterus)
01/2018 - 08/2015
3Liver Diseases (Liver Disease)
01/2018 - 08/2008
3Idiopathic Noncirrhotic Portal Hypertension
12/2015 - 08/2007
3Gallbladder Neoplasms (Gallbladder Cancer)
01/2014 - 03/2012
3Metaplasia
12/2012 - 06/2007

Drug/Important Bio-Agent (IBA)

21Proteins (Proteins, Gene)FDA Link
04/2022 - 09/2003
14Immunoglobulin G (IgG)IBA
04/2022 - 06/2005
12MucinsIBA
01/2018 - 10/2002
10Immunoglobulins (Immunoglobulin)IBA
03/2021 - 07/2012
10Bile Pigments (Bilin)IBA
01/2014 - 11/2007
9Cadherins (E-Cadherin)IBA
07/2017 - 06/2002
9CytokinesIBA
01/2012 - 01/2003
8LigandsIBA
05/2014 - 06/2005
8Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
06/2010 - 04/2006
6Immune Checkpoint InhibitorsIBA
04/2022 - 01/2020
6NivolumabIBA
01/2022 - 01/2020
6Biological ProductsIBA
08/2020 - 09/2003
6Transforming Growth Factor beta1 (TGF beta 1)IBA
07/2010 - 04/2005
5CateninsIBA
06/2022 - 10/2009
5Messenger RNA (mRNA)IBA
04/2022 - 09/2003
5Sunitinib (Sutent)FDA Link
01/2022 - 01/2017
5Ursodeoxycholic Acid (Urso)FDA LinkGeneric
01/2021 - 01/2018
5EnzymesIBA
04/2019 - 03/2009
5Neural Cell Adhesion Molecules (Neural Cell Adhesion Molecule)IBA
09/2013 - 04/2008
5Pathogen-Associated Molecular Pattern MoleculesIBA
12/2012 - 06/2007
4Peptides (Polypeptides)IBA
09/2021 - 08/2006
4Pharmaceutical PreparationsIBA
10/2020 - 08/2010
4Biomarkers (Surrogate Marker)IBA
01/2020 - 01/2012
4AutoantibodiesIBA
12/2019 - 01/2003
4pazopanibFDA Link
11/2019 - 01/2018
4Adrenal Cortex Hormones (Corticosteroids)IBA
05/2019 - 09/2011
4AntigensIBA
01/2019 - 04/2005
4PAceinIBA
02/2015 - 02/2013
4DNA (Deoxyribonucleic Acid)IBA
01/2014 - 12/2002
4Chemokine CX3CL1IBA
10/2013 - 03/2005
4Toll-Like Receptors (Toll-Like Receptor)IBA
08/2011 - 11/2003
4PPAR gammaIBA
06/2010 - 06/2005
4NF-kappa B (NF-kB)IBA
02/2009 - 06/2007
3pembrolizumabIBA
10/2022 - 01/2022
3Docetaxel (Taxotere)FDA Link
06/2022 - 08/2019
3ICG 001IBA
06/2022 - 09/2017
3Hormones (Hormone)IBA
06/2022 - 01/2021
3B7-H1 AntigenIBA
11/2021 - 03/2017
3Collagen Type IV (Type IV Collagen)IBA
09/2021 - 02/2009
3gadolinium ethoxybenzyl DTPAFDA Link
04/2021 - 03/2011
3C-Reactive ProteinIBA
01/2020 - 12/2002
3Oxidoreductases (Dehydrogenase)IBA
01/2019 - 11/2003
3Cyclin D1IBA
10/2018 - 04/2005
3LipopolysaccharidesIBA
11/2017 - 03/2005
3Cyclooxygenase 2 (Cyclooxygenase-2)IBA
09/2017 - 01/2003
3Histidine (L-Histidine)FDA Link
09/2017 - 11/2012
3Cytidine DeaminaseIBA
07/2017 - 11/2012
3Tyrosine Kinase InhibitorsIBA
03/2016 - 10/2006
3Phenobarbital (Luminal)FDA Link
07/2014 - 08/2002
3Transcription Factors (Transcription Factor)IBA
05/2013 - 10/2008
3ChemokinesIBA
12/2012 - 02/2010
3Keratin-7 (Cytokeratin 7)IBA
12/2012 - 02/2003

Therapy/Procedure

26Therapeutics
06/2022 - 12/2002
8Drug Therapy (Chemotherapy)
10/2022 - 08/2010
8Castration
06/2022 - 10/2018
5Nephrectomy
01/2022 - 01/2018
4Hepatectomy
04/2015 - 01/2011